• Yttrium-90 (90 Y ) is a radioactive isotope of yttrium. Yttrium-90 has found a wide range of uses in radiation therapy to treat some forms of cancer. Along...
    12 KB (1,249 words) - 13:08, 9 December 2024
  • Thumbnail for Yttrium
    Yttrium is a chemical element; it has symbol Y and atomic number 39. It is a silvery-metallic transition metal chemically similar to the lanthanides and...
    58 KB (6,687 words) - 12:39, 5 December 2024
  • Thumbnail for Strontium-90
    Strontium-90 (90 Sr ) is a radioactive isotope of strontium produced by nuclear fission, with a half-life of 28.8 years. It undergoes β− decay into yttrium-90,...
    23 KB (2,178 words) - 00:54, 2 October 2024
  • Thumbnail for Radiopharmaceutical
    Radiopharmaceuticals, or medicinal radiocompounds, are a group of pharmaceutical drugs containing radioactive isotopes. Radiopharmaceuticals can be used...
    20 KB (673 words) - 08:23, 17 January 2024
  • overactive bone marrow, in which it is otherwise naturally metabolised. An yttrium-90 (90Y) colloidal suspension is used for radiosynovectomy in the knee joint...
    12 KB (1,294 words) - 12:04, 7 September 2024
  • Natural yttrium (39Y) is composed of a single isotope yttrium-89. The most stable radioisotopes are 88Y, which has a half-life of 106.6 days, and 91Y...
    18 KB (524 words) - 12:08, 10 October 2024
  • Thumbnail for Yttrium(III) oxide
    Yttrium oxide, also known as yttria, is Y2O3. It is an air-stable, white solid substance. The thermal conductivity of yttrium oxide is 27 W/(m·K). Yttrium...
    11 KB (1,035 words) - 13:17, 20 October 2024
  • Thumbnail for 90Y-DOTA-biotin
    90Y-DOTA-biotin consists of a radioactive substance (yttrium-90) complexed by a chelating agent (DOTA), which in turn is attached to the vitamin biotin...
    4 KB (438 words) - 22:48, 18 August 2023
  • Thumbnail for Radiation therapy
    and yttrium-90 to treat neuroendocrine tumors (peptide receptor radionuclide therapy). Another example is the injection of radioactive yttrium-90 or holmium-166...
    114 KB (13,666 words) - 16:00, 1 December 2024
  • Thumbnail for Hepatocellular carcinoma
    supplying the tumor with a radioisotope agent. The agent is typically Yttrium-90 (Y-90) incorporated into embolic microspheres that lodge in the tumor vasculature...
    91 KB (10,152 words) - 01:40, 14 November 2024
  • Thumbnail for Neuroendocrine tumor
    positive disease. The peptide receptor may be bound to lutetium-177, yttrium-90, indium-111 and other isotopes including alpha emitters. This is a highly...
    87 KB (8,009 words) - 05:16, 19 October 2024
  • Thumbnail for Selective internal radiation therapy
    commercially available microsphere for SIRT. Two of these use the radionuclide yttrium-90 (90Y) and are made of either glass (TheraSphere) or resin (SIR-Spheres)...
    41 KB (4,492 words) - 04:43, 8 March 2024
  • Thumbnail for Carcinoembryonic antigen
    that has been tested in phase I clinical trials with 111-In and 90-Yttrium. 111-In and 90-Y are β- emitters that are used in clinics for imaging and therapy...
    21 KB (2,283 words) - 11:44, 7 November 2024
  • Thumbnail for Edotreotide
    of peptide receptor radionuclide therapy. A phase I clinical trial of yttrium-90 labelled edotreotide concluded in 2011, aiming to investigated effects...
    8 KB (420 words) - 22:45, 12 September 2024
  • Thumbnail for Lutetium (177Lu) oxodotreotide
    radiolabeled somatostatin analog. Alternatives to 177Lu-dotatate include yttrium-90 dotatate or DOTATOC. The longer range of the beta particles emitted by...
    19 KB (1,408 words) - 09:37, 9 May 2024
  • Thumbnail for DOTA (chelator)
    linked to the monoclonal antibody tacatuzumab and chelating yttrium-90 DOTATOC chelating yttrium-90 DOTA-TATE The complex of Gd3+ and DOTA is used as a gadolinium-based...
    9 KB (841 words) - 13:02, 3 August 2024
  • Thumbnail for Nuclear medicine
    Condition Iodine-131-sodium iodide Hyperthyroidism and thyroid cancer Yttrium-90-ibritumomab tiuxetan (Zevalin) and Iodine-131-tositumomab (Bexxar) Refractory...
    39 KB (4,403 words) - 07:09, 2 November 2024
  • clivatuzumab (targeted at MUC1), is conjugated with tetraxetan, a chelator for yttrium-90, a radioisotope which destroys the tumour cells. The drug was developed...
    3 KB (126 words) - 16:42, 12 November 2023
  • Thumbnail for Fission products (by element)
    next-longest lived yttrium isotopes have half-lives of only 107 days (88Y) or 59 days (91Y). However, a small amount of yttrium-90 will be found in secular...
    34 KB (4,505 words) - 23:23, 22 November 2024
  • Thumbnail for Haemophilia
    Naccarato A, Pelagalli L, et al. (2017). "Acquired Hemophilia A After Hepatic Yttrium-90 Radioembolization: A Case Report". A&A Case Reports. 9 (12): 344–5. doi:10...
    62 KB (6,819 words) - 05:49, 7 December 2024
  • effective. This treatment involves attaching a radionuclide (Lutetium-177 or Yttrium-90) to a somatostatin analogue (octreotate or octreotide). This is a novel...
    6 KB (658 words) - 12:17, 12 August 2024
  • Thumbnail for Ibritumomab tiuxetan
    conjunction with the chelator tiuxetan, to which a radioactive isotope (either yttrium-90 or indium-111) is added. Tiuxetan is a modified version of DTPA whose...
    9 KB (746 words) - 05:56, 25 July 2024
  • Thumbnail for Yttrium (90Y) tacatuzumab tetraxetan
    antibody itself, tacatuzumab, is conjugated with tetraxetan, a chelator for yttrium-90, a radioisotope which destroys the tumour cells. "Statement On A Nonproprietary...
    2 KB (69 words) - 06:30, 31 December 2023
  • Thumbnail for Radioactivity in the life sciences
    radiometals thus radiolabeling the protein. This has been used for introducing Yttrium-90 onto a monoclonal antibody for therapeutic purposes and for introducing...
    18 KB (2,273 words) - 04:32, 30 October 2024
  • sample preparation. High-energy beta emitters, such as phosphorus-32 and yttrium-90 can also be counted in a scintillation counter without the cocktail, instead...
    5 KB (560 words) - 19:51, 20 August 2024
  • Thumbnail for Windscale fire
    (half-life 30 years), 189 TBq (37 g) each of strontium-90 (half-life 29 years) and its daughter yttrium-90, 9.12 TBq (4.0 kg) of plutonium-239 (half-life 24...
    63 KB (7,862 words) - 04:17, 11 December 2024
  • Thumbnail for Type 90 tank
    several upgrades to the fire-control system, including the addition of a Yttrium-Aluminium-Garnet laser rangefinder with a range of 300 to 5,000 meters...
    17 KB (1,801 words) - 21:16, 30 November 2024
  • Thumbnail for Radioimmunotherapy
    90Y-FF-21101 is a monoclonal antibody against P-cadherin radiolabeled with yttrium-90. It is one of several RIT treatments under investigation intending to...
    10 KB (1,010 words) - 10:13, 12 August 2024
  • Thumbnail for Radiation burn
    caesium-137 (550 keV), phosphorus-32 (1.71 MeV), strontium-90 (650 keV) and its daughter product yttrium-90 (2.3 MeV) damage deeper levels of the dermis and can...
    41 KB (4,540 words) - 23:41, 7 August 2024
  • substances: Osmic acid, rifampicin and rifamycin (i.e. chemosynovectomy) Yttrium-90, erbium-169, dysprosium-165 and rhenium-186 (radiosynovectomy) List of...
    6 KB (697 words) - 01:04, 31 August 2024